Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma.


AIM   We conducted a retrospective cohort study to investigate the efficacy of combination therapy with radiotherapy (RT) and zoledronic acid for bone metastases from hepatocellular carcinoma (HCC). Additionally, we investigated the efficacy of zoledronic acid for non-irradiated bone metastases. METHODS   This study consisted of 31 patients who had… (More)
DOI: 10.1111/j.1872-034X.2010.00729.x